Molecular design, synthesis and anticancer activity of new thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone)

A series of 11-substituted 9-hydroxy-3,5,10,11-tetrahydro-2H-benzo[6,7]thiochromeno[2,3-d][1,3]thiazole-2,5,10-triones 3.1–3.13 were synthesized via hetero-Diels-Alder reaction of 5-ene-4-thioxo-2-thiazolidinones and 5-hydroxy-1,4-naphthoquinone (juglone). The structure of newly synthesized compound...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of medicinal chemistry 2023-04, Vol.252, p.115304-115304, Article 115304
Hauptverfasser: Ivasechko, Iryna, Lozynskyi, Andrii, Senkiv, Julia, Roszczenko, Piotr, Kozak, Yuliia, Finiuk, Nataliya, Klyuchivska, Olga, Kashchak, Nataliya, Manko, Nazar, Maslyak, Zvenyslava, Lesyk, Danylo, Karkhut, Andriy, Polovkovych, Svyatoslav, Czarnomysy, Robert, Szewczyk, Olga, Kozytskiy, Andriy, Karpenko, Olexandr, Khyluk, Dmytro, Gzella, Andrzej, Bielawski, Krzysztof, Bielawska, Anna, Dzubak, Petr, Gurska, Sona, Hajduch, Marian, Stoika, Rostyslav, Lesyk, Roman
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 115304
container_issue
container_start_page 115304
container_title European journal of medicinal chemistry
container_volume 252
creator Ivasechko, Iryna
Lozynskyi, Andrii
Senkiv, Julia
Roszczenko, Piotr
Kozak, Yuliia
Finiuk, Nataliya
Klyuchivska, Olga
Kashchak, Nataliya
Manko, Nazar
Maslyak, Zvenyslava
Lesyk, Danylo
Karkhut, Andriy
Polovkovych, Svyatoslav
Czarnomysy, Robert
Szewczyk, Olga
Kozytskiy, Andriy
Karpenko, Olexandr
Khyluk, Dmytro
Gzella, Andrzej
Bielawski, Krzysztof
Bielawska, Anna
Dzubak, Petr
Gurska, Sona
Hajduch, Marian
Stoika, Rostyslav
Lesyk, Roman
description A series of 11-substituted 9-hydroxy-3,5,10,11-tetrahydro-2H-benzo[6,7]thiochromeno[2,3-d][1,3]thiazole-2,5,10-triones 3.1–3.13 were synthesized via hetero-Diels-Alder reaction of 5-ene-4-thioxo-2-thiazolidinones and 5-hydroxy-1,4-naphthoquinone (juglone). The structure of newly synthesized compounds was established by means of spectral data and a single-crystal X-ray diffraction analysis. The synthesized compounds were tested on a panel of cell lines representing different types of cancer as well as normal and pseudonormal cells and peripheral human blood lymphocytes. Compound 3.10 was found to be the most active derivative, exhibiting a cytotoxic effect similar to doxorubicin's one (IC50 ranged from 0.6 to 5.98 μM), but less toxic to normal and pseudonormal cells. All synthesized compounds were able to interact with DNA, although their anticancer activity did not correlate with the potency of interaction with DNA. The status of p53 in colorectal cancer cells correlated with the activity of the synthesized derivatives 3.1, 3.7, and 3.10. Compound 3.10 did not have an acute toxic effect on the body of С57BL/6 mice, unlike the well-known anticancer drug doxorubicin, which was used as a positive control. The injection of 3.10 (20 mg/kg) to mice had no effect on the counts of leukocytes, erythrocytes, platelets and hemoglobin level in their blood, in contrast to doxorubicin, which caused anemia and leukopenia, indicating bio-tolerance of 3.10in vivo. [Display omitted] •Novel thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone) were synthesized.•The structure of synthesized compounds was characterized by spectral data and X-ray diffraction analysis.•Compound 3.10 exhibited an anticancer cytotoxicity similar to doxorubicin but less toxic to normal and pseudonormal cells.•Compound 3.10 reduced mitochondrial membrane potential, induced apoptosis and DNA damage.•Compound 3.10 possessed low acute toxic effect on С57BL/6 mice.
doi_str_mv 10.1016/j.ejmech.2023.115304
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2793989256</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0223523423002702</els_id><sourcerecordid>2793989256</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-dce28821e5147c47e9112f764a597aecc19fa81dc4b11528b10b634a039e3f883</originalsourceid><addsrcrecordid>eNp9UcuKFTEQDaI419E_EMlyhJtrXv3aCMPgC0bc6EokpJPq6TR9k2uSHm33_rcZenTpoqiiOFWn6hyEnjN6YJTVr6YDTEcw44FTLg6MVYLKB2jHmrolglfyIdpRzgWpuJBn6ElKE6W0qil9jM5EQykTHd2h3x_DDGaZdcQWkrvxe5xWn8dSJ6y9LZGd0d5AxNpkd-vyisOAPfzAeXThtEbtw1e-F8R-Kw39q-xLuNcJLA4eV2RcbQw_V8L2knh9GvMYvi_OBw_4Ylpu5lK8fIoeDXpO8Ow-n6Mvb998vnpPrj-9-3B1eU2MpG0m1gBvW86gYrIxsoGOMT40tdRV12gwhnWDbpk1si968LZntK-F1FR0IIa2FefoYtt7iuUISFkdXTIwz9pDWJLiTSe6tuNVXaByg5oYUoowqFN0Rx1Xxai6M0BNajNA3RmgNgPK2It7hqU_gv039FfxAni9AaD8eesgqmQcFH2ti2CyssH9n-EPmwOZZg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2793989256</pqid></control><display><type>article</type><title>Molecular design, synthesis and anticancer activity of new thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone)</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Ivasechko, Iryna ; Lozynskyi, Andrii ; Senkiv, Julia ; Roszczenko, Piotr ; Kozak, Yuliia ; Finiuk, Nataliya ; Klyuchivska, Olga ; Kashchak, Nataliya ; Manko, Nazar ; Maslyak, Zvenyslava ; Lesyk, Danylo ; Karkhut, Andriy ; Polovkovych, Svyatoslav ; Czarnomysy, Robert ; Szewczyk, Olga ; Kozytskiy, Andriy ; Karpenko, Olexandr ; Khyluk, Dmytro ; Gzella, Andrzej ; Bielawski, Krzysztof ; Bielawska, Anna ; Dzubak, Petr ; Gurska, Sona ; Hajduch, Marian ; Stoika, Rostyslav ; Lesyk, Roman</creator><creatorcontrib>Ivasechko, Iryna ; Lozynskyi, Andrii ; Senkiv, Julia ; Roszczenko, Piotr ; Kozak, Yuliia ; Finiuk, Nataliya ; Klyuchivska, Olga ; Kashchak, Nataliya ; Manko, Nazar ; Maslyak, Zvenyslava ; Lesyk, Danylo ; Karkhut, Andriy ; Polovkovych, Svyatoslav ; Czarnomysy, Robert ; Szewczyk, Olga ; Kozytskiy, Andriy ; Karpenko, Olexandr ; Khyluk, Dmytro ; Gzella, Andrzej ; Bielawski, Krzysztof ; Bielawska, Anna ; Dzubak, Petr ; Gurska, Sona ; Hajduch, Marian ; Stoika, Rostyslav ; Lesyk, Roman</creatorcontrib><description>A series of 11-substituted 9-hydroxy-3,5,10,11-tetrahydro-2H-benzo[6,7]thiochromeno[2,3-d][1,3]thiazole-2,5,10-triones 3.1–3.13 were synthesized via hetero-Diels-Alder reaction of 5-ene-4-thioxo-2-thiazolidinones and 5-hydroxy-1,4-naphthoquinone (juglone). The structure of newly synthesized compounds was established by means of spectral data and a single-crystal X-ray diffraction analysis. The synthesized compounds were tested on a panel of cell lines representing different types of cancer as well as normal and pseudonormal cells and peripheral human blood lymphocytes. Compound 3.10 was found to be the most active derivative, exhibiting a cytotoxic effect similar to doxorubicin's one (IC50 ranged from 0.6 to 5.98 μM), but less toxic to normal and pseudonormal cells. All synthesized compounds were able to interact with DNA, although their anticancer activity did not correlate with the potency of interaction with DNA. The status of p53 in colorectal cancer cells correlated with the activity of the synthesized derivatives 3.1, 3.7, and 3.10. Compound 3.10 did not have an acute toxic effect on the body of С57BL/6 mice, unlike the well-known anticancer drug doxorubicin, which was used as a positive control. The injection of 3.10 (20 mg/kg) to mice had no effect on the counts of leukocytes, erythrocytes, platelets and hemoglobin level in their blood, in contrast to doxorubicin, which caused anemia and leukopenia, indicating bio-tolerance of 3.10in vivo. [Display omitted] •Novel thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone) were synthesized.•The structure of synthesized compounds was characterized by spectral data and X-ray diffraction analysis.•Compound 3.10 exhibited an anticancer cytotoxicity similar to doxorubicin but less toxic to normal and pseudonormal cells.•Compound 3.10 reduced mitochondrial membrane potential, induced apoptosis and DNA damage.•Compound 3.10 possessed low acute toxic effect on С57BL/6 mice.</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2023.115304</identifier><identifier>PMID: 37001390</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Animals ; Anticancer activity ; Antineoplastic Agents - chemistry ; Apoptosis ; Cell Line, Tumor ; Cell Proliferation ; DNA interaction ; Doxorubicin - pharmacology ; Drug design ; Drug Screening Assays, Antitumor ; Humans ; Juglone ; Mice ; Molecular docking ; Molecular Docking Simulation ; Molecular Structure ; Naphthoquinones - pharmacology ; Structure-Activity Relationship ; Thiazoles - chemistry ; Thiopyranothiazoles</subject><ispartof>European journal of medicinal chemistry, 2023-04, Vol.252, p.115304-115304, Article 115304</ispartof><rights>2023 The Authors</rights><rights>Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-dce28821e5147c47e9112f764a597aecc19fa81dc4b11528b10b634a039e3f883</citedby><cites>FETCH-LOGICAL-c408t-dce28821e5147c47e9112f764a597aecc19fa81dc4b11528b10b634a039e3f883</cites><orcidid>0000-0002-3322-0080</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejmech.2023.115304$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37001390$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ivasechko, Iryna</creatorcontrib><creatorcontrib>Lozynskyi, Andrii</creatorcontrib><creatorcontrib>Senkiv, Julia</creatorcontrib><creatorcontrib>Roszczenko, Piotr</creatorcontrib><creatorcontrib>Kozak, Yuliia</creatorcontrib><creatorcontrib>Finiuk, Nataliya</creatorcontrib><creatorcontrib>Klyuchivska, Olga</creatorcontrib><creatorcontrib>Kashchak, Nataliya</creatorcontrib><creatorcontrib>Manko, Nazar</creatorcontrib><creatorcontrib>Maslyak, Zvenyslava</creatorcontrib><creatorcontrib>Lesyk, Danylo</creatorcontrib><creatorcontrib>Karkhut, Andriy</creatorcontrib><creatorcontrib>Polovkovych, Svyatoslav</creatorcontrib><creatorcontrib>Czarnomysy, Robert</creatorcontrib><creatorcontrib>Szewczyk, Olga</creatorcontrib><creatorcontrib>Kozytskiy, Andriy</creatorcontrib><creatorcontrib>Karpenko, Olexandr</creatorcontrib><creatorcontrib>Khyluk, Dmytro</creatorcontrib><creatorcontrib>Gzella, Andrzej</creatorcontrib><creatorcontrib>Bielawski, Krzysztof</creatorcontrib><creatorcontrib>Bielawska, Anna</creatorcontrib><creatorcontrib>Dzubak, Petr</creatorcontrib><creatorcontrib>Gurska, Sona</creatorcontrib><creatorcontrib>Hajduch, Marian</creatorcontrib><creatorcontrib>Stoika, Rostyslav</creatorcontrib><creatorcontrib>Lesyk, Roman</creatorcontrib><title>Molecular design, synthesis and anticancer activity of new thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone)</title><title>European journal of medicinal chemistry</title><addtitle>Eur J Med Chem</addtitle><description>A series of 11-substituted 9-hydroxy-3,5,10,11-tetrahydro-2H-benzo[6,7]thiochromeno[2,3-d][1,3]thiazole-2,5,10-triones 3.1–3.13 were synthesized via hetero-Diels-Alder reaction of 5-ene-4-thioxo-2-thiazolidinones and 5-hydroxy-1,4-naphthoquinone (juglone). The structure of newly synthesized compounds was established by means of spectral data and a single-crystal X-ray diffraction analysis. The synthesized compounds were tested on a panel of cell lines representing different types of cancer as well as normal and pseudonormal cells and peripheral human blood lymphocytes. Compound 3.10 was found to be the most active derivative, exhibiting a cytotoxic effect similar to doxorubicin's one (IC50 ranged from 0.6 to 5.98 μM), but less toxic to normal and pseudonormal cells. All synthesized compounds were able to interact with DNA, although their anticancer activity did not correlate with the potency of interaction with DNA. The status of p53 in colorectal cancer cells correlated with the activity of the synthesized derivatives 3.1, 3.7, and 3.10. Compound 3.10 did not have an acute toxic effect on the body of С57BL/6 mice, unlike the well-known anticancer drug doxorubicin, which was used as a positive control. The injection of 3.10 (20 mg/kg) to mice had no effect on the counts of leukocytes, erythrocytes, platelets and hemoglobin level in their blood, in contrast to doxorubicin, which caused anemia and leukopenia, indicating bio-tolerance of 3.10in vivo. [Display omitted] •Novel thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone) were synthesized.•The structure of synthesized compounds was characterized by spectral data and X-ray diffraction analysis.•Compound 3.10 exhibited an anticancer cytotoxicity similar to doxorubicin but less toxic to normal and pseudonormal cells.•Compound 3.10 reduced mitochondrial membrane potential, induced apoptosis and DNA damage.•Compound 3.10 possessed low acute toxic effect on С57BL/6 mice.</description><subject>Animals</subject><subject>Anticancer activity</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Apoptosis</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation</subject><subject>DNA interaction</subject><subject>Doxorubicin - pharmacology</subject><subject>Drug design</subject><subject>Drug Screening Assays, Antitumor</subject><subject>Humans</subject><subject>Juglone</subject><subject>Mice</subject><subject>Molecular docking</subject><subject>Molecular Docking Simulation</subject><subject>Molecular Structure</subject><subject>Naphthoquinones - pharmacology</subject><subject>Structure-Activity Relationship</subject><subject>Thiazoles - chemistry</subject><subject>Thiopyranothiazoles</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UcuKFTEQDaI419E_EMlyhJtrXv3aCMPgC0bc6EokpJPq6TR9k2uSHm33_rcZenTpoqiiOFWn6hyEnjN6YJTVr6YDTEcw44FTLg6MVYLKB2jHmrolglfyIdpRzgWpuJBn6ElKE6W0qil9jM5EQykTHd2h3x_DDGaZdcQWkrvxe5xWn8dSJ6y9LZGd0d5AxNpkd-vyisOAPfzAeXThtEbtw1e-F8R-Kw39q-xLuNcJLA4eV2RcbQw_V8L2knh9GvMYvi_OBw_4Ylpu5lK8fIoeDXpO8Ow-n6Mvb998vnpPrj-9-3B1eU2MpG0m1gBvW86gYrIxsoGOMT40tdRV12gwhnWDbpk1si968LZntK-F1FR0IIa2FefoYtt7iuUISFkdXTIwz9pDWJLiTSe6tuNVXaByg5oYUoowqFN0Rx1Xxai6M0BNajNA3RmgNgPK2It7hqU_gv039FfxAni9AaD8eesgqmQcFH2ti2CyssH9n-EPmwOZZg</recordid><startdate>20230405</startdate><enddate>20230405</enddate><creator>Ivasechko, Iryna</creator><creator>Lozynskyi, Andrii</creator><creator>Senkiv, Julia</creator><creator>Roszczenko, Piotr</creator><creator>Kozak, Yuliia</creator><creator>Finiuk, Nataliya</creator><creator>Klyuchivska, Olga</creator><creator>Kashchak, Nataliya</creator><creator>Manko, Nazar</creator><creator>Maslyak, Zvenyslava</creator><creator>Lesyk, Danylo</creator><creator>Karkhut, Andriy</creator><creator>Polovkovych, Svyatoslav</creator><creator>Czarnomysy, Robert</creator><creator>Szewczyk, Olga</creator><creator>Kozytskiy, Andriy</creator><creator>Karpenko, Olexandr</creator><creator>Khyluk, Dmytro</creator><creator>Gzella, Andrzej</creator><creator>Bielawski, Krzysztof</creator><creator>Bielawska, Anna</creator><creator>Dzubak, Petr</creator><creator>Gurska, Sona</creator><creator>Hajduch, Marian</creator><creator>Stoika, Rostyslav</creator><creator>Lesyk, Roman</creator><general>Elsevier Masson SAS</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3322-0080</orcidid></search><sort><creationdate>20230405</creationdate><title>Molecular design, synthesis and anticancer activity of new thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone)</title><author>Ivasechko, Iryna ; Lozynskyi, Andrii ; Senkiv, Julia ; Roszczenko, Piotr ; Kozak, Yuliia ; Finiuk, Nataliya ; Klyuchivska, Olga ; Kashchak, Nataliya ; Manko, Nazar ; Maslyak, Zvenyslava ; Lesyk, Danylo ; Karkhut, Andriy ; Polovkovych, Svyatoslav ; Czarnomysy, Robert ; Szewczyk, Olga ; Kozytskiy, Andriy ; Karpenko, Olexandr ; Khyluk, Dmytro ; Gzella, Andrzej ; Bielawski, Krzysztof ; Bielawska, Anna ; Dzubak, Petr ; Gurska, Sona ; Hajduch, Marian ; Stoika, Rostyslav ; Lesyk, Roman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-dce28821e5147c47e9112f764a597aecc19fa81dc4b11528b10b634a039e3f883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Animals</topic><topic>Anticancer activity</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Apoptosis</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation</topic><topic>DNA interaction</topic><topic>Doxorubicin - pharmacology</topic><topic>Drug design</topic><topic>Drug Screening Assays, Antitumor</topic><topic>Humans</topic><topic>Juglone</topic><topic>Mice</topic><topic>Molecular docking</topic><topic>Molecular Docking Simulation</topic><topic>Molecular Structure</topic><topic>Naphthoquinones - pharmacology</topic><topic>Structure-Activity Relationship</topic><topic>Thiazoles - chemistry</topic><topic>Thiopyranothiazoles</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ivasechko, Iryna</creatorcontrib><creatorcontrib>Lozynskyi, Andrii</creatorcontrib><creatorcontrib>Senkiv, Julia</creatorcontrib><creatorcontrib>Roszczenko, Piotr</creatorcontrib><creatorcontrib>Kozak, Yuliia</creatorcontrib><creatorcontrib>Finiuk, Nataliya</creatorcontrib><creatorcontrib>Klyuchivska, Olga</creatorcontrib><creatorcontrib>Kashchak, Nataliya</creatorcontrib><creatorcontrib>Manko, Nazar</creatorcontrib><creatorcontrib>Maslyak, Zvenyslava</creatorcontrib><creatorcontrib>Lesyk, Danylo</creatorcontrib><creatorcontrib>Karkhut, Andriy</creatorcontrib><creatorcontrib>Polovkovych, Svyatoslav</creatorcontrib><creatorcontrib>Czarnomysy, Robert</creatorcontrib><creatorcontrib>Szewczyk, Olga</creatorcontrib><creatorcontrib>Kozytskiy, Andriy</creatorcontrib><creatorcontrib>Karpenko, Olexandr</creatorcontrib><creatorcontrib>Khyluk, Dmytro</creatorcontrib><creatorcontrib>Gzella, Andrzej</creatorcontrib><creatorcontrib>Bielawski, Krzysztof</creatorcontrib><creatorcontrib>Bielawska, Anna</creatorcontrib><creatorcontrib>Dzubak, Petr</creatorcontrib><creatorcontrib>Gurska, Sona</creatorcontrib><creatorcontrib>Hajduch, Marian</creatorcontrib><creatorcontrib>Stoika, Rostyslav</creatorcontrib><creatorcontrib>Lesyk, Roman</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ivasechko, Iryna</au><au>Lozynskyi, Andrii</au><au>Senkiv, Julia</au><au>Roszczenko, Piotr</au><au>Kozak, Yuliia</au><au>Finiuk, Nataliya</au><au>Klyuchivska, Olga</au><au>Kashchak, Nataliya</au><au>Manko, Nazar</au><au>Maslyak, Zvenyslava</au><au>Lesyk, Danylo</au><au>Karkhut, Andriy</au><au>Polovkovych, Svyatoslav</au><au>Czarnomysy, Robert</au><au>Szewczyk, Olga</au><au>Kozytskiy, Andriy</au><au>Karpenko, Olexandr</au><au>Khyluk, Dmytro</au><au>Gzella, Andrzej</au><au>Bielawski, Krzysztof</au><au>Bielawska, Anna</au><au>Dzubak, Petr</au><au>Gurska, Sona</au><au>Hajduch, Marian</au><au>Stoika, Rostyslav</au><au>Lesyk, Roman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular design, synthesis and anticancer activity of new thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone)</atitle><jtitle>European journal of medicinal chemistry</jtitle><addtitle>Eur J Med Chem</addtitle><date>2023-04-05</date><risdate>2023</risdate><volume>252</volume><spage>115304</spage><epage>115304</epage><pages>115304-115304</pages><artnum>115304</artnum><issn>0223-5234</issn><eissn>1768-3254</eissn><abstract>A series of 11-substituted 9-hydroxy-3,5,10,11-tetrahydro-2H-benzo[6,7]thiochromeno[2,3-d][1,3]thiazole-2,5,10-triones 3.1–3.13 were synthesized via hetero-Diels-Alder reaction of 5-ene-4-thioxo-2-thiazolidinones and 5-hydroxy-1,4-naphthoquinone (juglone). The structure of newly synthesized compounds was established by means of spectral data and a single-crystal X-ray diffraction analysis. The synthesized compounds were tested on a panel of cell lines representing different types of cancer as well as normal and pseudonormal cells and peripheral human blood lymphocytes. Compound 3.10 was found to be the most active derivative, exhibiting a cytotoxic effect similar to doxorubicin's one (IC50 ranged from 0.6 to 5.98 μM), but less toxic to normal and pseudonormal cells. All synthesized compounds were able to interact with DNA, although their anticancer activity did not correlate with the potency of interaction with DNA. The status of p53 in colorectal cancer cells correlated with the activity of the synthesized derivatives 3.1, 3.7, and 3.10. Compound 3.10 did not have an acute toxic effect on the body of С57BL/6 mice, unlike the well-known anticancer drug doxorubicin, which was used as a positive control. The injection of 3.10 (20 mg/kg) to mice had no effect on the counts of leukocytes, erythrocytes, platelets and hemoglobin level in their blood, in contrast to doxorubicin, which caused anemia and leukopenia, indicating bio-tolerance of 3.10in vivo. [Display omitted] •Novel thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone) were synthesized.•The structure of synthesized compounds was characterized by spectral data and X-ray diffraction analysis.•Compound 3.10 exhibited an anticancer cytotoxicity similar to doxorubicin but less toxic to normal and pseudonormal cells.•Compound 3.10 reduced mitochondrial membrane potential, induced apoptosis and DNA damage.•Compound 3.10 possessed low acute toxic effect on С57BL/6 mice.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>37001390</pmid><doi>10.1016/j.ejmech.2023.115304</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-3322-0080</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0223-5234
ispartof European journal of medicinal chemistry, 2023-04, Vol.252, p.115304-115304, Article 115304
issn 0223-5234
1768-3254
language eng
recordid cdi_proquest_miscellaneous_2793989256
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animals
Anticancer activity
Antineoplastic Agents - chemistry
Apoptosis
Cell Line, Tumor
Cell Proliferation
DNA interaction
Doxorubicin - pharmacology
Drug design
Drug Screening Assays, Antitumor
Humans
Juglone
Mice
Molecular docking
Molecular Docking Simulation
Molecular Structure
Naphthoquinones - pharmacology
Structure-Activity Relationship
Thiazoles - chemistry
Thiopyranothiazoles
title Molecular design, synthesis and anticancer activity of new thiopyrano[2,3-d]thiazoles based on 5-hydroxy-1,4-naphthoquinone (juglone)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T06%3A59%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20design,%20synthesis%20and%20anticancer%20activity%20of%20new%20thiopyrano%5B2,3-d%5Dthiazoles%20based%20on%205-hydroxy-1,4-naphthoquinone%20(juglone)&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=Ivasechko,%20Iryna&rft.date=2023-04-05&rft.volume=252&rft.spage=115304&rft.epage=115304&rft.pages=115304-115304&rft.artnum=115304&rft.issn=0223-5234&rft.eissn=1768-3254&rft_id=info:doi/10.1016/j.ejmech.2023.115304&rft_dat=%3Cproquest_cross%3E2793989256%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2793989256&rft_id=info:pmid/37001390&rft_els_id=S0223523423002702&rfr_iscdi=true